International journal of molecular sciences · 2021
Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cordido Adrian, Vizoso-Gonzalez Marta, Garcia-Gonzalez Miguel A
Аннотация
Autosomal recessive polycystic kidney disease (ARPKD) is a rare disorder and one of the most severe forms of polycystic kidney disease, leading to end-stage renal disease (ESRD) in childhood. PKHD1 is the gene that is responsible for the vast majority of ARPKD. However, some cases have been related to a new gene that was recently identified (DZIP1L gene), as well as several ciliary genes that can mimic a ARPKD-like phenotypic spectrum. In addition, a number of molecular pathways involved in the ARPKD pathogenesis and progression were elucidated using cellular and animal models. However, the function of the ARPKD proteins and the molecular mechanism of the disease currently remain incompletely understood. Here, we review the clinics, treatment, genetics, and molecular basis of ARPKD, highlighting the most recent findings in the field.
Предметные рубрики MeSH
AnimalsBiomarkersClinical Trials as TopicCombined Modality TherapyDiagnosis, DifferentialDisease ManagementDisease SusceptibilityGenetic Association StudiesGenetic Predisposition to DiseaseHumansMutationPhenotypePolycystic Kidney, Autosomal RecessiveQuantitative Trait LociReceptors, Cell SurfaceSignal TransductionStructure-Activity RelationshipTreatment Outcome